RxDoctor Payments Data

Tammy Saylor

Family · Gray, KYNPI 1821439746

Payments from drug & device makers

$2,422in general payments, 2019–2025

Across 150 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$814
  • Novo Nordisk$343
  • Lilly USA, LLC$213
  • Merck$174
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$152
  • Bayer$98
  • plus $628 from 17 others

What the payments were for

  • Food & beverage$2,422100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,422 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$80,731
JardianceEmpagliflozin92$57,799
Ondansetron Hcl123$39,589
MounjaroTirzepatide35$36,057
LinzessLinaclotide49$27,006
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$26,125
VraylarCariprazine Hcl14$19,198
EntrestoSacubitril/Valsartan20$18,146
JanuviaSitagliptin Phosphate28$16,214
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$13,461
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,410
Spiriva HandihalerTiotropium Bromide15$8,553
Aimovig AutoinjectorErenumab-Aooe11$7,785
Naloxone Hcl121$6,976
MovantikNaloxegol Oxalate15$6,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$343$80,73180 claims
Boehringer IngelheimJardiance$56$57,79992 claims
AbbVieLinzess, Vraylar, Synthroid$814$46,85377 claims
Lilly USA, LLCMounjaro$213$36,05735 claims
GSKTrelegy Ellipta, Breo Ellipta$63$31,32654 claims
MerckJanuvia$174$16,21428 claims
AstraZenecaBreztri Aerosphere$75$11,41017 claims
PfizerPrempro$16$2,85012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Gray

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →